SCHEMBL24011094

SCHEMBL24011094

CN(C(=O)CCCCCNC(=O)NCc1ccc(Cl)cc1)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 5/20 0.47
▸ HDAC3 O15379 4/20 0.47
▸ HDAC4 P56524 4/20 0.47
▸ HDAC7 Q8WUI4 4/20 0.47
▸ HDAC2 Q92769 4/20 0.47
▸ HDAC10 Q969S8 4/20 0.47
▸ HDAC11 Q96DB2 4/20 0.47
▸ HDAC8 Q9BY41 4/20 0.47
▸ HDAC6 Q9UBN7 4/20 0.47
▸ HDAC9 Q9UKV0 4/20 0.47
▸ HDAC5 Q9UQL6 4/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ LSS P48449 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011408 0.88 HDAC1 (0.48) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011068 0.88 CASR (0.49) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011495 0.88 FES (0.46) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011597 0.85 PPIB (0.55) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011496 0.82 NAMPT (0.43) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011098 0.80 HDAC6 (0.47) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL30306667 0.80 HDAC6 (0.47) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011601 0.80 KDM4E (0.55) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL24011406 0.79 HDAC1 (0.52) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL30306652 0.78 HDAC1 (0.49) HDAC1HDAC3HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
WO-2021226276-A2 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT HDAC1 51/4885HDAC3 216/4885HDAC4 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback